SOL vs VRCA
Comparison between Emeren Group Ltd American Depositary Shares, each representing 10 shares (SOL, Company) and Verrica Pharmaceuticals Inc (VRCA, Company).
SOL is from the Technology sector, while VRCA is from the Healthcare sector.
5-Year PerformanceSOL has outperformed VRCA, delivering a return of +2.8% compared to -44.1%
SOL vs VRCA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
SOL vs VRCA - Historical Returns
Returns include dividend reinvestment.
SOL vs VRCA - Annual Returns (2017 - 2026)
Returns include dividend reinvestment.
| Year | SOL | VRCA |
|---|---|---|
| 2026 | +0.00% | -30.96% |
| 2025 | N/A | +18.27% |
| 2024 | N/A | -89.72% |
| 2023 | N/A | +154.17% |
| 2022 | N/A | -71.02% |
| 2021 | N/A | -23.92% |
| 2020 | N/A | -24.57% |
| 2019 | -13.64% | +99.87% |
| 2018 | -64.50% | -53.43% |
| 2017 | +222.53% | N/A |
SOL vs VRCA Drawdown Comparison
The maximum drawdown for SOL was -82.72%, occurring on Dec 28, 2018. This drawdown has not yet recovered.
The maximum drawdown for VRCA was -98.39%, occurring on Nov 4, 2025. This drawdown has not yet recovered.
The current SOL drawdown is -71.10%. The current VRCA drawdown is -97.18%.
| Rank | SOL | VRCA |
|---|---|---|
| #1 | -82.72% Jan 29, 2018 - Dec 28, 2018 | -98.39% Jun 25, 2018 - Nov 4, 2025 |
| #2 | -36.66% Nov 27, 2017 - Dec 4, 2017 | -1.04% Jun 20, 2018 - Jun 25, 2018 |
| #3 | -36.36% Oct 13, 2017 - Nov 27, 2017 | N/A |
| #4 | -4.68% Jan 16, 2018 - Jan 18, 2018 | N/A |
| #5 | -2.64% Dec 5, 2017 - Dec 8, 2017 | N/A |
| #6 | -2.62% Dec 18, 2017 - Dec 21, 2017 | N/A |
| #7 | -2.45% Jan 2, 2018 - Jan 4, 2018 | N/A |
| #8 | -2.41% Jan 8, 2018 - Jan 10, 2018 | N/A |
| #9 | -2.01% Dec 11, 2017 - Dec 13, 2017 | N/A |
| #10 | -1.65% Dec 28, 2017 - Jan 2, 2018 | N/A |
| #11 | -0.88% Dec 21, 2017 - Dec 27, 2017 | N/A |
Correlation
Correlation between SOL and VRCA is 0.51 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks